In this report, LP Information covers the current scenario (being the base year 2017) and the growth prospects of the global Mitomycin C market for 2018-2023.
In the mitomycin C market, mitomycin C is an antibiotic that acts as a double-stranded DNA alkylating agent. Covalently cross-links DNA, inhibiting DNA synthesis and cell proliferation. It acts through reductive activation either through low pH or NAD (P) H: quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al. ; Cummings et al. ..).
In recent years, the global mitomycin C market experienced a rapidly upward trend, with an average growth rate of 4.76%. In 2016, global revenues from mitomycin C are nearly $ 119.83m; actual production is approximately 17,370K Unit.
The global average price of Mitomycin C is on an increasing trend, from 6.30 USD / Unit in 2012 to 6.90 USD / Unit in 2016. With the situation of the global economy, prices will have an increasing trend in the next five years.
Mitomycin C classification includes 2 Mg, 10 Mg, 40 Mg and others. The proportion of 2 Mg in 2016 is approximately 41.5%, and the proportion is on a decreasing trend from 2012 to 2016.
Mitomycin C is widely used in cancer treatment, ophthalmic use, and other fields. The largest proportion of mitomycin C is cancer treatment, and the proportion in 2016 is 69%. The trend of cancer treatment is declining.
Japan is the largest supplier of Mitomycin C, with a production market share of almost 26.5% in 2016. India is the second largest supplier of Mitomycin C Media, with a production market share of almost 25% in 2016.
North America is the largest consumer location, with a consumer market share of almost 36% in 2016. After North America, Europe is the second largest consumer location with a consumer market share of 32 , 6%.
Over the next five years, LPI (LP Information) projects that Mitomycin C will register a CAGR of -2.3% in terms of revenue, reaching $ 100 million in 2023, up from $ 120 million in 2017.
This report presents a complete overview, market shares, and growth opportunities of the Mitomycin C market by product type, application, key manufacturers, and key regions.
To calculate the size of the market, LP Information considers the value and volume generated by the sales of the following segments:
Segmentation by product type:
2 mg
10 mg
40 mg
Other
Segmentation by application:
Cancer treatment
Ophthalmic use
Others
This report also divides the market by region:
Americas
USA
Canada
Mexico
Brazil
APAC
porcelain
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Inquire here and check the discount for the report @:
https://www.reporthive.com/enquiry.php?id=1565680&req_type=disc
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendors / manufacturers in the market. The key manufacturers covered in this report:
Kyowa-kirin
Intas Pharmaceuticals
It accommodates you
Bristol-Myers Squibb
Aspen
European pharmaceutical specialty
Alkem Laboratories
Varifarma
APOGEPHA
Additionally, this report looks at the key factors influencing market growth, opportunities, challenges, and risks faced by key manufacturers and the market as a whole. It also looks at key emerging trends and their impact on present and future development.
Investigate objectives:
Study and analyze global mitomycin C consumption (value and volume) by key regions / countries, product type and application, historical data from 2013 to 2017 and forecast for 2023.
To understand the structure of Mitomycin C market by identifying its various subsegments.
Focuses on the world’s leading Mitomycin C manufacturers to define, describe and analyze sales volume, value, market share, market competition landscape, SWOT analysis, and development plans for years to come. .
To analyze Mitomycin C with respect to individual growth trends, future prospects, and its contribution to the total market.
Share detailed information on the key factors influencing market growth (growth potential, opportunities, drivers, challenges, and industry-specific risks).
To project the consumption of the Mitomycin C submarkets, with respect to key regions (along with their respective key countries).
· Analyze competitive developments such as expansions, agreements, new product launches and market acquisitions.
· Strategically profile key players and comprehensively analyze their growth strategies.
Read the full study of the research report @: https://www.reporthive.com/enquiry.php?id=1565680&req_type=purch
Table of Contents:
Chapter One: Scope of the Report
Chapter Two: Executive Summary
Chapter Three: Global Mitomycin C By Players
Chapter Four: Mitomycin C by Region
Chapter Five: Americas
Chapter Six: APAC
Chapter Seven: Europe
Chapter Eight: Middle East and Africa
Chapter Nine: Market Drivers, Challenges, and Trends
Chapter Ten: Marketing, Distributors, and Customer
Read more …
List of tables and figures:
Figure Mitomycin C consumed in cancer treatment
Figure Global Mitomycin C Market: Cancer Treatment (2013-2018) (K Units)
Figure Global Mitomycin C Market: Cancer Treatment (2013-2018) (Million USD)
Figure Year-on-year growth of global cancer treatment (millions of dollars)
Figure Mitomycin C consumed in ophthalmic use
Figure Global Mitomycin C Market: Ophthalmic Use (2013-2018) (K Units)
Figure Global Mitomycin C Market: Ophthalmic Use (2013-2018) (USD Million)
Figure Year-on-year growth of global ophthalmic use ($ Millions) and know more …